Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 28, 2015; 21(40): 11273-11281
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11273
Table 2 Vaccines recommended in patients with inflammatory bowel disease and mechanisms associated with impaired response in these patients
VaccineImmunogenImpaired responseFactors associated with a lower responseMechanisms associated with lower immunogenicity
HBVRecombinant proteinYesAge[20,21,23], immunosuppressive or anti-TNF therapy[20,21,23]Not described
HPVRecombinant proteinNo--
InfluenzaInactivated virusYesImmunosuppressive therapy[8]Not described
PneumococcusPolysaccharidesYesImmunosuppressive and/or anti-TNF therapy[9,10,55]Conflicting results about memory B cells[60,62]
TetanusInactivated toxoidUnclearNone describedDefects in the development of IgG-secreting plasma cells[65]
Measles-mump-rubellaLive attenuated virusNo--
VaricellaLive attenuated virusNo--
Herpes zosterLive attenuated virusNo--